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Abstract 
In developıng countries such as Iraq, hepatitis B (HBV) and C virus (HCV) are leading health care problems. 
The aim of this paper was to evaluate the frequency of HBV and HCV in healthy individuals selected for the 
recruitment in police services in Duhok city. In the study, blood samples from 566 candidates of police 
recruitment were collected and tested for HBV surface antigen (HBs Ag) and HCV antibody (AB) positivity by 
ELISA. It was found that 41/566 (7.2%) subjects were positive for HBs Ag. None of the recruited subjects was 
positive for HCV AB. To conclude, the prevalence of HBs Ag positivity was high in newly recruited police 
officers. Further study recruiting larger sample size is needed to confirm such a result.   
Keywords: HBV; HCV; Iraq; Duhok 
1. Introduction 
Viral hepatitis is a global public health problem. In developıng countries such as Iraq, HBV and HCV are 
leading health care problems [1-3].  
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Worldwide, it is estimated that 350 million subjects are chronically infected with HBV while 170 million 
subjects are chronically infected with HCV [1-3]. Both HBV and HCV are blood borne viruses and can 
predispose to liver cirrhosis and hepatocellular carcinoma [1-3]. 
Based on the prevalence of carriers of hepatitis B surface antigen in the general population, countries are 
classified as having high (>8%), intermediate (2-7%), or low endemicity ( < 2%) [3, 4]. Iraq is amongst the 
countries of intermediate prevalence [5].  Some group, for example those who are on haemodialysis, transplants, 
and multiple blood transfusions, drug users and healthcare workers are at increasing risk of acquiring the 
infection [6, 7]. In a study conducted in Europe, it was shown that about 85% of vaccine went to the healthcare 
workers, who account for only 5 to 10% of reported cases of hepatitis B. While healthcare workers should 
certainly be immunised, this high risk strategy will not control hepatitis B on a population basis [8]. 
Identification of high risk group in the community is needed and should be targeted by a vaccination 
programme.  
Blood-borne diseases including HBV and HCV among prison inmates are higher than the general population 
[9]. This high prevalence might be due to drug using and high-risk addiction-related behaviors, having multiple 
sexual partners and homosexuality, prison life style and limited educational opportunities of this population 
group [9]. On the other hand police officer and due to the nature of their work are at increased risk of HBV and 
HCV [10]. Although occupational exposures of blood borne pathogens are well studied in health care providers, 
limited data exists to assess occupational exposures to police officers. Also, base line information should be 
available about the prevalence of infection with these viruses in this group. In this paper, we aimed at studying 
the prevalence of HBV and HCV in candidates for police recruitment in Duhok city, Kurdistan region, Iraq.  
2. Materials and Methods 
2.1 Blood Samples    
A cross-sectional study was conducted in Duhok city. All newly recruited police officers were recruited in this 
study. A 5cc syringe and needle were used to bleed approximately 5 ml of blood from each donor. Then the 
blood samples were centrifuged at 1500 rpm for 3 min to obtain serum.  
2.2 ELISA 
The HCV AB (fourth generation) and the hepatitis B-specific HBs antigen were studied by commercial 
DIA.PRO diagnostic Bioprobes ELISA kit (Italy) following manufacturer’s instruction.  A mouse monoclonal 
antibody specific for HBsAg is fixed to the surface of microwells. Patient’s serum was added to the micro-well 
with a mouse monoclonal antibody specific for HBsAg together with a second mouse monoclonal antibody, 
conjugated with Horseradish Peroxidase (HRP).  Then micro-wells were washed to remove unbound serum 
proteins and HRP conjugate. 
The substrate was then added after blocking the enzymatic reaction; its optical density was measured by an 
ELISA reader.  
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Fourth generation enzyme immunoassay for the determination HCV AB was used.  Microplates were coated 
with HCV-specific antigens derived from core peptide, recombinant NS3, NS4 and NS5 peptides. Serum 
samples were then added and HCV AB were captured, if present, by the antigens. After washing out all the 
other components of the sample, in the 2nd incubation bound HCV antibodies, IgG and IgM as well, were 
detected by the addition of polyclonal specific antibodies labelled with peroxidase (HRP). 
The substrate was then added after blocking the enzymatic reaction, its optical density was measured by an 
ELISA reader. 
2.3 Ethics 
The research protocol was approved by the Ethical committee of polytechnique university of Duhok. 
3. Results 
3.1 Characteristics of donors  
Over the period of the study from February to May 2015, 566 subjects were screened for HBs Ag and HCV AB. 
Among them, 453 were male and 113 were female. The average age of our subjects was 25±13 years.  
3.2 HBs Ag and HCV AB positivity 
It was found that 41/566 (7.2%) subjects showed positive results for HBs Ag (table 1). The prevalence of HBs 
Ag positivity was 13/113 (11.5%) in female while it was 28/453 (6%) in male. None of the recruited subjects 
was positive for HCV AB.  
Table 1: The distribution of HBV cases according to the age 
Age in year No of cases 
18-19 3 
20-29 20 
30-39 11 
>40 7 
Total 41 
 
4. Discussion 
HBV and HCV are transmitted easily through parenteral route with infected blood and secretions. In two reports 
studying the prevalence of HBV positivity in Iraq (Babylon and Najaf cities), the prevalence was found to be 
around 0.7%, while the prevalence was found to be as high as 3.5% in Kerbala [11, 12].  In a study conducted in 
Egypt recruiting healthy volunteer blood donors, HBV positivity was found in 5% of the donors [13]. Similarly, 
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in a study conducted in Kuwait, the prevalence of HBsAg positivity amongst Kuwaiti nationals and non-Kuwaiti 
Arab was found to be 1.1% and 3.5%, respectively [14]. In another study conducted in Saudi, it was found that 
the HBV positivity was 3.8% [15]. Police officers are at high risk of HBV and HCV. This probably due the 
nature of their work and may reflect increases in the prevalence of blood borne viral infection. In a previous 
study, the prevalence of HBV was studied in officers before the engagement in their duties and few officers 
showed positivity afterward, which suggested unreported exposure [10]. It was shown also that the group most 
at risk was officers on ordinary street duty  [10].  In our study, it was found that the prevalence of HBV was 
7.2%. This is much higher than that reported previously in the community. Different reports showed that the 
prevalence of HBV in Iraq is around 2%. This high prevalence might be due to that the sample was not collected 
randomly and further population based study is needed to determine the prevalence of HBV. The prevalence of 
HCV is very low in Iraq [5, 16]. In our study, none of the subjects showed positive results for HCV AB. This 
might return back to the relative small sample size recruited in this study. Our study is important because it gave 
baseline information about the prevalence of prospective police officers who would be in a risk of HBV and 
HCV due to the nature of their job. Our study has limitations. First, and perhaps most importantly, we studied 
the prevalence of HBV and HCV in a special group and this did not reflect the prevalence of the community. 
Also, our sample was small and from a limited geographical region and therefore it might not reflect the 
prevalence in whole Iraq. It is recommended that further study with a larger sample from different geographical 
region of Iraq to be performed. Most officers can avoid contamination with hepatitis B by adopting precautions 
such as taking care with needles and wearing gloves when dealing with bleeding accident victims. Moreover, 
vaccination programme should be considered to cover this group.  
5. Conclusions 
Our study was performed to estimate the prevalence of HBV and HCV in newly recruited police officers. It was 
found that around 7%of the tested population was positive for HBV while none of the tested subjects was 
infected with HCV. The prevalence of HBV in this group seemed to be higher than the general population of 
Iraq. Further study is needed recruiting larger sample to explore this subject.  
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